Haemostat Market Size Was Valued at USD 4.75 Billion in 2023, and is Projected to Reach USD 9.33 Billion by 2032, Growing at a CAGR of 7.9% From 2024-2032.

The treatment of healthcare interventional pulmonology is a rather narrow segment of medical practice that involves the diagnosis and subsequent treatment of diseases that affect people’s lungs with the help of minimally invasive techniques.

Interventional Radiology (IR) is a branch of medicine, which employs the utilization of imaging in the performance of the surgical operation. These procedures are mostly undertaken through minimal access cuts hence giving options to the conventional broad incisions. It is applied to identify, and treat, and manage conditions with less period of recovery and fewer complications.

The Inflammatory Bowel Disease (IBD) market refers to the products, external modalities, methods, strategies, service and treatments that targets IBD majorly including Crohn and Colitis and Ulcerative Colitis. IBD is a long-standing inflammatory disease of unknown cause that involves the gastrointestinal tract in a relapsing and remitting pattern. It extends to drugs and substances used in the treatment of severe diseases and includes therapeutic interventions such as drugs, biologics aimed at managing symptoms, achieving remission or enhancing patient’s quality of life once affected by such diseases. Given the increasing prevalence of IBD in population, caused by genetic factors, environmental conditions and lifestyle, the market has a great potential for development.

The Injectable Drugs Market has products which are administered to the body through injections; IM, Sub-Q, and IV products.

In Vivo CRO Market Size Was Valued at USD 4.64 Billion in 2023, and is Projected to Reach USD 9.51 Billion by 2032, Growing at a CAGR of 8.3% From 2024-2032.